1-Isothiocyanato-2-phenylethane
AlkaPlorer ID: AK003455
Synonym: (2-Isothiocyanatoethyl)benzene, 2-Phenylethyl isothiocyanate, Phenethyl isothiocyanate
IUPAC Name: 2-isothiocyanatoethylbenzene
Structure
SMILES: S=C=NCCC1=CC=CC=C1
InChI: InChI=1S/C9H9NS/c11-8-10-7-6-9-4-2-1-3-5-9/h1-5H,6-7H2
InChIKey: IZJDOKYDEWTZSO-UHFFFAOYSA-N
Reference
Headspace volatiles of whole plants and macerated plant parts of Brassica and Sinapis
PubChem CID: 16741
CAS: 2257-09-2
LOTUS: LTS0215765
SuperNatural Ⅲ: SN0159373
NPASS: NPC244738
COCONUT: CNP0391669
Source
Properties Information
Molecule Weight: 163.245
TPSA?: 12.36
MolLogP?: 2.3319
Number of H-Donors: 0
Number of H-Acceptors: 2
RingCount: 1
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Homo sapiens | 786-0 | GI50 | 187.5 | nM | None |
| Homo sapiens | A498 | GI50 | 430.53 | nM | None |
| Homo sapiens | A549 | Activity | 4.5 | % | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | A549 | Activity | 7.5 | % | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | A549 | Activity | 8.0 | % | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | A549 | Activity | 10.5 | % | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | A549 | Activity | 11.0 | % | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | A549 | Activity | 14.5 | % | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | A549 | Activity | 22.5 | % | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | A549 | Activity | 29.0 | % | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | A549 | Activity | 39.0 | % | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | A549 | Activity | 40.5 | % | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | A549 | Activity | 51.0 | % | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | A549 | Activity | 54.0 | % | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | A549 | Activity | 75.0 | % | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | A549 | Activity | nan | None | 10.1021/jm101199t |
| Homo sapiens | A549 | GI50 | 2393.32 | nM | None |
| Homo sapiens | A549 | IC50 | 16800.0 | nM | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | A549 | Ratio | 3.5 | None | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | A549 | Ratio | 3.8 | None | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | A549 | Ratio | 7.1 | None | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | ACHN | GI50 | 1559.55 | nM | None |
| Homo sapiens | AMP-activated protein kinase, AMPK | Activity | nan | None | 10.1021/np300049b |
| Homo sapiens | Caco-2 | IC50 | 14000.0 | nM | 10.1021/jm800993r |
| Homo sapiens | Canalicular multispecific organic anion transporter 1 | Activity | 94.0 | % | 10.1021/jm7015683 |
| Homo sapiens | CCRF-CEM | GI50 | 185.78 | nM | None |
| Homo sapiens | Cellular tumor antigen p53 | Activity | nan | None | 10.1021/jm101199t |
| Homo sapiens | COLO 205 | GI50 | 762.08 | nM | None |
| Homo sapiens | Cytochrome P450 2A13 | Kd | 430.0 | nM | 10.1124/dmd.112.045161 |
| Homo sapiens | Cytochrome P450 2A13 | Ki | 3800.0 | nM | 10.1124/dmd.112.045161 |
| Homo sapiens | Cytochrome P450 2A6 | Kd | 6200.0 | nM | 10.1124/dmd.112.045161 |
| Homo sapiens | Cytochrome P450 2A6 | Ki | 1700.0 | nM | 10.1124/dmd.112.045161 |
| Homo sapiens | Cytochrome P450 2E1 | Activity | 26.0 | % | 10.1124/dmd.112.050609 |
| Homo sapiens | Cytochrome P450 2E1 | Activity | 27.0 | % | 10.1124/dmd.112.050609 |
| Homo sapiens | Cytochrome P450 2E1 | Activity | 42.0 | % | 10.1124/dmd.112.050609 |
| Homo sapiens | Cytochrome P450 2E1 | Activity | 64.0 | % | 10.1124/dmd.112.050609 |
| Homo sapiens | Cytochrome P450 2E1 | Activity | 82.0 | % | 10.1124/dmd.112.050609 |
| Homo sapiens | Cytochrome P450 2E1 | Activity | 85.0 | % | 10.1124/dmd.112.050609 |
| Homo sapiens | Cytochrome P450 2E1 | Activity | 93.0 | % | 10.1124/dmd.112.050609 |
| Homo sapiens | Cytochrome P450 2E1 | Activity | 100.0 | % | 10.1124/dmd.112.050609 |
| Homo sapiens | Cytochrome P450 2E1 | Activity | nan | None | 10.1124/dmd.112.050609 |
| Homo sapiens | Cytochrome P450 2E1 | Drug metabolism | nan | None | 10.1124/dmd.112.050609 |
| Homo sapiens | Cytochrome P450 2E1 | Inhibition | nan | % | 10.1124/dmd.112.050609 |
| Homo sapiens | Cytochrome P450 2E1 | Ki | 9980.0 | nM | 10.2174/138920005774330639 |
| Homo sapiens | Cytochrome P450 2E1 | Ki | 11000.0 | nM | 10.1124/dmd.112.050609 |
| Homo sapiens | Cytochrome P450 2E1 | Kinact | 0.23 | /min | 10.1124/dmd.112.050609 |
| Homo sapiens | Cytochrome P450 2E1 | Kinact | 0.339 | min-1 | 10.2174/138920005774330639 |
| Homo sapiens | Cytochrome P450 2E1 | PPB | nan | % | 10.1124/dmd.112.050609 |
| Homo sapiens | Cytochrome P450 2E1 | Ratio | 12.0 | None | 10.1124/dmd.112.050609 |
| Homo sapiens | Cytochrome P450 2E1 | T1/2 | 0.05 | hr | 10.1124/dmd.112.050609 |
| Homo sapiens | DLD-1 | GI50 | 59.57 | nM | None |
| Homo sapiens | DLD-1 | IC50 | 54590.0 | nM | 10.1016/j.ejmech.2020.113149 |
| Homo sapiens | DMS-114 | GI50 | 381.94 | nM | None |
| Homo sapiens | DMS-273 | GI50 | 254.68 | nM | None |
| Homo sapiens | EKVX | GI50 | 16788.04 | nM | None |
| Homo sapiens | HCC 2998 | GI50 | 412.1 | nM | None |
| Homo sapiens | HCT-116 | Activity | nan | None | 10.1021/jm101199t |
| Homo sapiens | HCT-116 | GI50 | 452.9 | nM | None |
| Homo sapiens | HCT-15 | GI50 | 228.03 | nM | None |
| Homo sapiens | HepG2 | Activity | nan | None | 10.1016/j.bmcl.2010.01.044 |
| Homo sapiens | HL-60 | GI50 | 384.59 | nM | None |
| Homo sapiens | HOP-62 | GI50 | 370.68 | nM | None |
| Homo sapiens | HT-1080 | IC50 | 15000.0 | nM | 10.1021/jm800993r |
| Homo sapiens | HT-29 | GI50 | 219.28 | nM | None |
| Homo sapiens | Hypoxia inducible factors; HIF-1-alpha, HIF-2-alpha | IC50 | 7500.0 | nM | 10.1021/np300049b |
| Homo sapiens | Hypoxia inducible factors; HIF-1-alpha, HIF-2-alpha | Inhibition | nan | % | 10.1021/np300049b |
| Homo sapiens | IGROV-1 | GI50 | 434.51 | nM | None |
| Homo sapiens | K562 | GI50 | 225.94 | nM | None |
| Homo sapiens | KM12 | GI50 | 238.78 | nM | None |
| Homo sapiens | KM-20L2 | GI50 | 729.46 | nM | None |
| Homo sapiens | Liver microsome | Drug metabolism | nan | None | 10.1124/dmd.112.050609 |
| Homo sapiens | LoVo | IC50 | 9800.0 | nM | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | LoVo | IC50 | 13500.0 | nM | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | LoVo | IC50 | 13500.0 | nM | 10.1016/j.bmcl.2015.11.045 |
| Homo sapiens | LOX IMVI | GI50 | 193.64 | nM | None |
| Homo sapiens | LXFL 529 | GI50 | 212.32 | nM | None |
| Homo sapiens | M14 | GI50 | 460.26 | nM | None |
| Homo sapiens | M19-MEL | GI50 | 753.36 | nM | None |
| Homo sapiens | Macrophage migration inhibitory factor | IC50 | 1600.0 | nM | 10.1016/j.ejmech.2015.02.012 |
| Homo sapiens | Macrophage migration inhibitory factor | IC50 | 16000.0 | nM | 10.1016/j.ejmech.2015.02.012 |
| Homo sapiens | Malme-3M | GI50 | 963.83 | nM | None |
| Homo sapiens | MCF7 | Activity | nan | None | 10.1021/acs.jmedchem.0c01971 |
| Homo sapiens | MCF7 | Activity | nan | None | 10.1021/jm101199t |
| Homo sapiens | MCF7 | IC50 | 16300.0 | nM | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | MDA-MB-231 | Activity | nan | None | 10.1021/acs.jmedchem.0c01971 |
| Homo sapiens | MDA-MB-231 | Activity | nan | None | 10.1021/jm101199t |
| Homo sapiens | MDA-MB-231 | IC50 | 38000.0 | nM | 10.1021/jm800993r |
| Homo sapiens | MDA-MB-468 | Activity | nan | None | 10.1021/acs.jmedchem.0c01971 |
| Homo sapiens | MDA-MB-468 | Activity | nan | None | 10.1021/jm101199t |
| Homo sapiens | Mitogen-activated protein kinase; ERK1/ERK2 | Activity | nan | None | 10.1021/np300049b |
| Homo sapiens | MOLT-4 | GI50 | 529.66 | nM | None |
| Homo sapiens | mTORC1 | Inhibition | nan | % | 10.1021/np300049b |
| Homo sapiens | Multidrug resistance-associated protein 1 | Activity | 2.0 | fold | 10.1023/a:1020460700877 |
| Homo sapiens | NCI-H226 | GI50 | 1489.36 | nM | None |
| Homo sapiens | NCI-H23 | GI50 | 452.9 | nM | None |
| Homo sapiens | NCI-H322M | GI50 | 1778.28 | nM | None |
| Homo sapiens | NCI-H460 | GI50 | 97.27 | nM | None |
| Homo sapiens | NCI-H522 | GI50 | 193.2 | nM | None |
| Homo sapiens | NCI-H596 | Activity | nan | None | 10.1021/jm101199t |
| Homo sapiens | OVCAR-3 | GI50 | 612.35 | nM | None |
| Homo sapiens | OVCAR-3 | IC50 | 23200.0 | nM | 10.1021/np800233q |
| Homo sapiens | OVCAR-4 | GI50 | 2142.89 | nM | None |
| Homo sapiens | OVCAR-5 | GI50 | 1552.39 | nM | None |
| Homo sapiens | OVCAR-8 | GI50 | 1327.39 | nM | None |
| Homo sapiens | PC-3 | IC50 | 24000.0 | nM | 10.1021/jm800993r |
| Homo sapiens | P-glycoprotein 1 | Activity | nan | None | 10.1002/jps.20101 |
| Homo sapiens | Probable ubiquitin carboxyl-terminal hydrolase FAF-X | K | 150.0 | /M/s | 10.1016/j.bmcl.2018.11.055 |
| Homo sapiens | RPMI-8226 | GI50 | 179.47 | nM | None |
| Homo sapiens | RXF 393 | GI50 | 442.59 | nM | None |
| Homo sapiens | SF-268 | GI50 | 1061.7 | nM | None |
| Homo sapiens | SF-295 | GI50 | 1573.98 | nM | None |
| Homo sapiens | SF-539 | GI50 | 207.49 | nM | None |
| Homo sapiens | SK-MEL-2 | GI50 | 401.79 | nM | None |
| Homo sapiens | SK-MEL-28 | GI50 | 709.58 | nM | None |
| Homo sapiens | SK-MEL-5 | GI50 | 325.09 | nM | None |
| Homo sapiens | SK-OV-3 | GI50 | 1717.91 | nM | None |
| Homo sapiens | SN12C | GI50 | 319.15 | nM | None |
| Homo sapiens | SNB-19 | GI50 | 1725.84 | nM | None |
| Homo sapiens | SNB-75 | GI50 | 2654.61 | nM | None |
| Homo sapiens | SNB-78 | GI50 | 818.46 | nM | None |
| Homo sapiens | Solute carrier organic anion transporter family member 1B1 | Inhibition | -16.4 | % | 10.1021/jm300212s |
| Homo sapiens | Solute carrier organic anion transporter family member 1B3 | Inhibition | 12.3 | % | 10.1021/jm300212s |
| Homo sapiens | Solute carrier organic anion transporter family member 2B1 | Inhibition | -32.0 | % | 10.1021/jm300212s |
| Homo sapiens | SR | GI50 | 350.75 | nM | None |
| Homo sapiens | SW480 | Activity | nan | None | 10.1021/jm101199t |
| Homo sapiens | SW480 | IC50 | 35550.0 | nM | 10.1016/j.ejmech.2020.113149 |
| Homo sapiens | SW-620 | GI50 | 310.46 | nM | None |
| Homo sapiens | T47D | IC50 | 9700.0 | nM | 10.1016/j.bmcl.2011.05.113 |
| Homo sapiens | T98G | IC50 | 100000.0 | nM | 10.1021/jm800993r |
| Homo sapiens | TK-10 | GI50 | 812.83 | nM | None |
| Homo sapiens | Transient receptor potential cation channel subfamily A member 1 | Activity | nan | None | 10.1021/acs.jnatprod.5b00272 |
| Homo sapiens | Transient receptor potential cation channel subfamily A member 1 | EC50 | 370.0 | nM | 10.1021/acs.jnatprod.5b00272 |
| Homo sapiens | Transient receptor potential cation channel subfamily A member 1 | EC50 | 10000.0 | nM | 10.1021/jm100062h |
| Homo sapiens | Transient receptor potential cation channel subfamily A member 1 | max activation | 94.0 | % | 10.1021/acs.jnatprod.5b00272 |
| Homo sapiens | U-251 | GI50 | 794.33 | nM | None |
| Homo sapiens | UACC-257 | GI50 | 885.12 | nM | None |
| Homo sapiens | UACC-62 | GI50 | 839.46 | nM | None |
| Homo sapiens | UACC-903 | Activity | 40.0 | % | 10.1021/jm800993r |
| Homo sapiens | UACC-903 | Activity | nan | None | 10.1021/jm800993r |
| Homo sapiens | UACC-903 | IC50 | 12000.0 | nM | 10.1021/jm800993r |
| Homo sapiens | Ubiquitin carboxyl-terminal hydrolase 7 | K | nan | None | 10.1016/j.bmcl.2018.11.055 |
| Homo sapiens | UO-31 | GI50 | 1588.55 | nM | None |
| Homo sapiens | Vanilloid receptor | Activity | nan | None | 10.1021/acs.jnatprod.5b00272 |
| Homo sapiens | Vanilloid receptor | EC50 | 180000.0 | nM | 10.1021/acs.jnatprod.5b00272 |
| Homo sapiens | Vanilloid receptor | max activation | 43.0 | % | 10.1021/acs.jnatprod.5b00272 |
| Homo sapiens | XF498 | GI50 | 2393.32 | nM | None |
| Meloidogyne javanica | Meloidogyne javanica | LC50 | 4.15 | ug.mL-1 | 10.1016/j.cropro.2010.09.004 |
| Meloidogyne javanica | Meloidogyne javanica | LC90 | 6.96 | ug ml-1 | 10.1016/j.cropro.2010.09.004 |
| Meloidogyne javanica | Meloidogyne javanica | mortality | 60.75 | % | 10.1016/j.cropro.2010.09.004 |
| Meloidogyne javanica | Meloidogyne javanica | mortality | 79.63 | % | 10.1016/j.cropro.2010.09.004 |
| Mus musculus | MEF | IC50 | 4700.0 | nM | 10.1021/np300049b |
| Mus musculus | MEF | IC50 | 8000.0 | nM | 10.1021/np300049b |
| Mus musculus | Mus musculus | Activity | nan | None | 10.1021/jm800993r |
| Mus musculus | Transient receptor potential cation channel subfamily M member 8 | Activity | nan | None | 10.1021/acs.jnatprod.5b00272 |
| Rattus norvegicus | Cytochrome P450 2B1 | mechanism based inhibition | nan | None | 10.2174/138920005774330639 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | EC50 | 114000.0 | nM | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | EC50 | 144000.0 | nM | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | EC50 | 650000.0 | nM | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | GI | 5.0 | % | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | GI | 24.3 | % | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | GI | 42.7 | % | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | GI | 51.3 | % | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | GI | 59.7 | % | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | GI | 64.0 | % | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | GI | 92.5 | % | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | GI | 100.0 | % | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | Inhibition | 6.7 | % | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | Inhibition | 12.5 | % | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | Inhibition | 26.7 | % | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | Inhibition | 55.0 | % | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | Inhibition | 57.5 | % | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | Inhibition | 66.7 | % | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | Inhibition | 70.0 | % | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | Inhibition | 76.7 | % | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | Inhibition | 82.5 | % | 10.1002/ps.2126 |
| Sclerotinia sclerotiorum | Sclerotinia sclerotiorum | Inhibition | 100.0 | % | 10.1002/ps.2126 |
| None | ADMET | Activity | nan | None | 10.1021/acs.jnatprod.5b00272 |
| None | ADMET | Ratio | 0.064 | None | 10.1124/dmd.112.045161 |
| None | ADMET | Ratio Ki | 2.2 | None | 10.1124/dmd.112.045161 |
| None | Leukemia 60 cell line | GC50 | 0.84 | uM | 10.1016/s0960-894x(99)00574-0 |
| None | Leukemia 60 cell line | TC50 | 1.37 | uM | 10.1016/s0960-894x(99)00574-0 |
| None | NON-PROTEIN TARGET | Activity | 12.0 | % | 10.1021/np800233q |
| None | NON-PROTEIN TARGET | Activity | 81.0 | % | 10.1021/np800233q |
| None | NON-PROTEIN TARGET | Activity | nan | None | 10.1021/np800233q |
| None | NON-PROTEIN TARGET | IC50 | 7000.0 | nM | 10.1021/np800233q |
| None | NON-PROTEIN TARGET | IC50 | 9800.0 | nM | 10.1016/j.bmcl.2015.11.045 |
| None | NON-PROTEIN TARGET | IC50 | 20000.0 | nM | 10.1021/np800233q |
| None | Unchecked | Activity | nan | None | 10.1021/acs.jmedchem.0c01971 |
| None | Unchecked | Activity | nan | None | 10.1021/jm101199t |
| None | Unchecked | Activity | nan | None | 10.1021/np300049b |
| None | Unchecked | FC | 3.0 | None | 10.1021/np300049b |
| None | Unchecked | Inhibition | nan | % | 10.1021/acs.jmedchem.0c01971 |
| None | Unchecked | Inhibition | nan | % | 10.1021/np300049b |
